FDA lifts clinical hold on Ocugen's Covid-19 vaccine study; stock skyrockets
February 18, 2022 at 18:09 PM EST
The FDA in November temporarily put the brakes on Ocugen's plan to test Covaxin in the United States.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|